The compounding industry’s trade group, the International Academy of Compounding Pharmacists, strongly opposed the bill in its final form. It said in a statement that if the goal was to avoid another outbreak like the one last fall, “the American public must know that this bill will not accomplish that goal.”
The group said in another statement that the bill “will without question result in patients’ inability to obtain access to needed medications,” and expressed concern that it would grant the F.D.A. “sweeping, unprecedented authority in determining what pharmaciescan compound.”
No comments:
Post a Comment